proMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2

NCT05590143 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

784

Enrollment

OTHER

Sponsor class

Conditions

Acute Kidney Injury
Cardiac Surgery
Sodium-Glucose Transporter 2 Inhibitor

Interventions

DRUG: Dapagliflozin 10 MG Oral Tablet [Farxiga]
DRUG: Placebo

Sponsor

Amsterdam UMC

Collaborators

[object Object]